Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fentanyl sublingual - Orexo

Next Previous
X
Search
Drug Profile

Fentanyl sublingual - Orexo

Alternative Names: Abstral; EN-3267; Fentanyl citrate sublingual tablets; Fentanyl transmucosal - Orexo; KW-2246; OX-20; Rapinyl

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Orexo
  • Developer Galena Biopharma; Kyowa Kirin; Kyowa Kirin International; Paladin Labs
  • Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer pain

Most Recent Events

  • 02 Aug 2023 Kyowa Kirin enters deal to enter into a joint venture with Grunenthal for Fentanyl sublingual (Abstral®) for cancer pain
  • 19 Jan 2017 Sentynl Therapeutics has been acquired by Zydus Cadila
  • 03 May 2016 Re-launched for Cancer pain by Sentnyl Therapeutics in USA (Sublingual)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top